Meyer W R, Randall H W, Graves W L
Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia.
J Reprod Med. 1990 Jun;35(6):649-53.
Fifty-eight women in preterm labor were selected randomly to receive either oral nifedipine or intravenous ritodrine hydrochloride. In comparison to ritodrine, nifedipine had similar tocolytic efficacy with fewer adverse maternal and fetal side effects. On Doppler studies nifedipine had an insignificant effect on umbilical blood flow. Preliminary data suggest that nifedipine is a safe, effective and well-tolerated tocolytic agent. It may prove to be a suitable alternative to ritodrine hydrochloride, especially for women in whom beta-sympathomimetics are contraindicated.
随机选取58名早产妇女,分别给予口服硝苯地平或静脉注射盐酸利托君。与利托君相比,硝苯地平具有相似的宫缩抑制疗效,对母婴的副作用较少。在多普勒研究中,硝苯地平对脐血流的影响不显著。初步数据表明,硝苯地平是一种安全、有效且耐受性良好的宫缩抑制剂。它可能被证明是盐酸利托君的合适替代品,特别是对于禁用β-拟交感神经药的妇女。